Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MEIP

First Strategy, Now MEI Pharma: Litecoin Joins Bitcoin As Treasury Asset

MEI Pharma (NASDAQ:MEIP) has launched a $100 million Litecoin (CRYPTO: LTC) treasury program, backed by Titan Partners Group and crypto investment firm GSR.

Benzinga · Jul 18, 2025

4 Pharma Stocks to Watch for Surprising Gains in June

Amid growing demand for specialty drugs and increasing adoption of emerging technology in pharmaceutical manufacturing, the pharma industry is witnessing steady expansion. Therefore, quality pharmaceutical stocks Zoetis (ZTS), Viatris (VTRS), MEI Pharma (MEIP), and Amphastar Pharmaceuticals (AMPH) could be ideal additions to your watchlist. Keep reading….

StockNews.com · May 28, 2024

Top 4 Pharma Stocks to Consider This Month

With growing medical needs globally, R&D initiatives, and rapid adoption of emerging technologies like genAI, the pharma industry is well-poised to experience robust expansion. Thus, investors could consider buying top pharma stocks MEI Pharma (MEIP), Hypera (HYPMY), Aurinia Pharmaceuticals (AUPH), and Bayer (BAYRY) this month. Read on.

StockNews.com · May 13, 2024

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Pharma Stocks Outperforming the Competition

The growing demand for innovative drugs, the use of advanced technologies, and growing global healthcare needs boost the pharmaceutical industry’s long-term growth prospects. Therefore, fundamentally strong pharma stocks Viatris (VTRS), Wave Life Sciences (WVE), and MEI Pharma (MEIP) might be ideal additions to your portfolio. Read on.

StockNews.com · Mar 20, 2024

5 Top Stocks Trading Under $2

The stock market has been under pressure since the beginning of the year due to multi-decade high inflation, the potential for aggressive Federal Reserve interest rate hikes, and Russia’s invasion of Ukraine. But with peace talks between Russia and Ukraine underway, the volatility in the markets is expected to decline.…

StockNews.com · Mar 31, 2022

Analysts Cut Price Target On MEI Pharma As Stock Falls To 52-Week Low After Zandelisib Update

The FDA crushed MEI Pharma Inc's (NASDAQ: MEIP) hopes of winning accelerated approval for its PI3K inhibitor, zandelisib, on the strength of phase 2 data.

Benzinga · Mar 25, 2022

Coverage From

People

Dipanjan BanchurSince

722 stories

Charlie Lee

11 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Medical Pharmaceuticals

Rave Restaurant Group Inc

Bayer Aktiengesellschaft

12 stories

Wave Life Sciences Ltd

12 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.